Low grade chronic inflammation in women with polycystic ovarian syndrome

Kelly, Chris C. J., Lyall, Helen, Petrie, John R., Gould, Gwyn W., Connell, John M. C., Sattar, Naveed·2001·The Journal of Clinical Endocrinology & Metabolism

Cited by (639)

Items 401–500 of 639

  1. Correlation and predictive value of systemic immune-inflammation index for dyslipidemia in patients with polycystic ovary syndrome
    Xinyue Zhou, Yixiao Tian, Xuehong Zhang · 2024 · BMC Women s Health
  2. Multiracial Cytokine Profiling Reveals Immune Dysregulation not Chronic Inflammation in Polycystic Ovary Syndrome
    Gabriela Pacheco Sánchez, Rebecca Herrera, Margareta Danuta Pisarska, Ricardo Azziz, Dequina Nicholas, Jessica L. Chan · 2025 · The Journal of Clinical Endocrinology & Metabolism
  3. Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.
    Aldo Eugenio Calogero, Viola Calabrò, M. Catanuso, Rosita Angela Condorelli, Sandro La Vignera · 2011 · PubMed
  4. Study of Trace Elements Selenium, Copper, Zinc and Manganese Level in Polycystic Ovary Syndrome (PCOS)
    Amel H Mohmmed, Nadhum A.N. Awad, Adnan Jassim Mohammed Al‐Fartosy · 2019 · International Journal for Research in Applied Sciences and Biotechnology
  5. Urinary vitamin D-binding protein as a marker of ovarian reserve
    Sanglin Li, Lina Hu, Chanyu Zhang · 2021 · Reproductive Biology and Endocrinology
  6. Correlation of Markers of Inflammation with Hormonal, Metabolic Parameters, Insulin Resistance and Adiposity Indices in First-Degree Relatives of Patient with Polycystic Ovary Syndrome
    Jeeban Pradhan, Ipsita Mishra, Roma Rattan, Arun Kumar Choudhury, Anoj Kumar Baliarsinha · 2022 · Journal of Human Reproductive Sciences
  7. The Effect of Green Coffee Supplementation on Lipid Profile, Glycemic Indices, Inflammatory Biomarkers and Anthropometric Indices in Iranian Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial
    Mehrnoush Meshkani, Ahmad Saedisomeolia, Mir Saeed Yekaninejad, Seyed Ahmad Mousavi, Azam Ildarabadi, Marzieh Vahid Dastjerdi · 2022 · Clinical Nutrition Research
  8. The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women
    Ioana Rada Popa Ilie, Carmen Emanuela Pepene, Ioan Marian, Teodora Mocan, Georgeta Maria Hazi, Gh Dragotoiu, Razvan Ilie, Lucian Constantin MOCAN, Ileana Duncea · 2010 · Open Medicine
  9. Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?
    Mohsen Gharakhani, Nosrat Neghab, Marzie Sanuie Farimani · 2011 · PubMed Central
  10. Polycystic Ovarian Condition May Be a Risk Factor for Ovarian Tumor Development in the Laying Hen Model of Spontaneous Ovarian Cancer
    Hyun Ju Lee, Janice M. Bahr, Pincas Bitterman, Sanjib Basu, Sameer Sharma, Jacques S. Abramowicz, Animesh Barua · 2018 · Journal of Immunology Research
  11. The Effect of Green Tea on IL-6 and CRP level in Model of Polycystic Ovary Syndrome as an Inflammation State
    Habibeh Ghafurniyan, Mohammad Nabiuni, Latifeh Karimzadeh · 2014 · International Journal of Cellular and Molecular Biotechnology
  12. Review: Diabetes in pregnancy: insulin resistance, obesity and placental dysfunction
    Anjum Doshani, Justin C. Konje · 2009 · The British Journal of Diabetes
  13. Association Between Menstrual Irregularity and Dry Eye Disease
    Jae‐Yen Song, Minho Kim, Jisun Paik, Hyun Seung Kim, Kyung‐Sun Na · 2015 · Cornea
  14. The use of insulin sensitising agents in ovulation induction in women with Polycystic Ovary Syndrome
    Richard Fleming · 2006 · HORMONES
  15. Extrinsic and Intrinsic Responses in the Development and Progression of Atherosclerosis
    Mariya Kuk, Natalie C. Ward, Girish Dwivedi · 2021 · Heart Lung and Circulation
  16. Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
    Thomas Paterakis, Evanthia Diamanti‐Kandarakis · 2014 · Current Obesity Reports
  17. Salivary Interleukin-6 Levels among Polycystic Ovary Syndrome Patients with and Without Chronic Periodontitis – A Comparative Study
    Arun Varghese, Pratebha Balu, Saravanakumar Ravindran, Jananni Muthu, K Vineela · 2019 · Contemporary Clinical Dentistry
  18. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome
    Mustafa Can, Cevdet Duran, İbrahim Güney, Halis Elmas, Mehmet Emin Ayhan, Said Sami Erdem · 2020 · Clínica e Investigación en Arteriosclerosis
  19. Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome
    Frank González, John P. Kirwan, Neal S. Rote, Judi Minium · 2014 · American Journal of Obstetrics and Gynecology
  20. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome
    Sigrun Kjøtrød, Pål Romundstad, Vidar von Dûring, Arne Sunde, Sven Magnus Carlsen · 2007 · Fertility and Sterility
  21. Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and hyperandrogenemia
    Ioana Rada Popa Ilie, Carmen Emanuela Pepene, Ileana Duncea, Razvan Ilie · 2008 · Open Medicine
  22. Insulin resistance: what is its role in the polycystic ovary syndrome?
    Paolo Moghetti · 2002 · Current Opinion in Endocrinology & Diabetes
  23. Long-term health consequences of polycystic ovary syndrome
    Eleni Κousta, Stephen Franks · 2001 · Cambridge University Press eBooks
  24. miRNA-mRNA Network in PBMCs of PCOS Women Identifies Overactivated Stress-Activated Kinases
    Meera B. Krishna, Betcy Susan Johnson, Madavan Vasudevan, Sathy M. Pillai, Malini Laloraya · 2023 · Cellular Physiology and Biochemistry
  25. Evaluation of Microbial Profile in Patients with Polycystic Ovary Syndrome and Periodontal Disease: A Case-Control Study.
    Reshma Achu Joseph, Supraja Ajitkumar, Subbusamy Kanakasabapathy Balaji, Muthukumar Santhanakrishnan · 2023 · PubMed Central
  26. Journey through the gut-inflammation axis in polycystic ovary syndrome: the microbiota's role in shaping inflammatory pathways.
    Ujjawal Sharma, Anidrisha Sahu, Neelam Thakur, R. Choudhary, Himanshu Shekhar, Shafiul Haque, H. Tuli, A. Aubakirova, Bunty Sharma · 2025 · Molecular and Cellular Biochemistry
  27. Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder
    Lingxia Ha, Yu-Dong Du, Xiaoxiao Qu, Jinjuan Wang · 2023 · Diabetes Metabolic Syndrome and Obesity
  28. The therapeutic effect of anti-CD19 antibody on DHEA-induced PCOS mice
    Ting Wang, Xingliang Xiong, Na Xiao, Yizhong Yan, Xiaoyang Liu, Qi Xie, Xian Wei Su, Maosheng Chen, Jing Peng, Siqi Wang et al. · 2024 · International Immunopharmacology
  29. Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome
    AbdulHamid Zarġar, Mohd Ashraf Ganie, KhalidJamal Farooqui, Mohd Ashraf Bhat, Rashid Mir, Zafar A. Shah, Syed Douhath, SyedHussain Mir, Fouzia Rashid, Shazia Naqshi et al. · 2012 · Indian Journal of Endocrinology and Metabolism
  30. Serum levels of resistin and hsCRP in women with PCOS
    İlyas Çapoğlu, Fuat Erdem, Abdullah Uyanık, Hamdullah Turhan · 2009 · Open Medicine
  31. Effect of colchicine on polycystic ovary syndrome: an experimental study
    İlay Gözükara, Neslihan Pınar, Oğuzhan Özcan, Tümay Özgür, Recep Dokuyucu, Raziye Keskin Kurt, Suna Kabil Kucur, Ayşe Nur Aksoy · 2015 · Archives of Gynecology and Obstetrics
  32. Polymorphisms of vascular cell adhesion molecule1 (VCAM1) in polycystic ovary syndrome determined by quantitative real-time polymerase chain reaction and melting curve analysis
    Müge Kanmaz-Özer, Pervin Vural, Semra Doğru‐Abbasoğlu, Ali Gedikbaşı, Esra Çil, Berrin Karadağ, Müjdat Uysal · 2011 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  33. How to Stay Heart Healthy in 2011: Considerations for the Primary Prevention of Cardiovascular Disease in Women
    Melinda Baughman Davis, Claire S. Duvernoy · 2011 · Women s Health
  34. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes
    F. Moro, Anna Tropea, Elisa Scarinci, Alex Federico, Clara DE SIMONE, Giacomo Caldarola, Emanuele Leoncini, Stefania Boccia, Antonio Lanzone, Rosanna Apa · 2015 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  35. The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
    Mahfuz Turan, Rıfki Üçler, Mehmet Fatih Garça, Zehra Kurdoğlu, Hakan Çankaya, Abdurrahman Ayral, Nazım Bozan, Ahmet Faruk Kıroğlu, Mertihan Kurdoğlu · 2016 · Medical Science Monitor
  36. Women’s Health
    Melinda R. Ring · 2017 · Primary Care Clinics in Office Practice
  37. Prenatal Testosterone Exposure Induces Insulin Resistance, Uterine Oxidative Stress and pro-Inflammatory Status in Rats
    Ferreira, Silvana Rocío, Goyeneche, Alicia Alejandra, Heber, María Florencia, Abruzzese, Giselle Adriana, Ferrer, Maria José, Telleria, Carlos Marcelo, Motta, Alicia Beatriz · 2021 · Molecular and Cellular Endocrinology
  38. POINCARE PLOT OF HEART RATE VARIABILITY: QUANTITATIVE ANALYSIS OF SYMPATHETIC NERVOUS ACTIVITY IN NON-OBESE POLYCYSTIC OVARY SYNDROME PATIENTS
    Malathi Balamurugan, Balamurugan Balamurugan, Gomathi Ramanathan · 2016 · Journal of Evolution of Medical and Dental Sciences
  39. Polycystic Ovary Syndrome, Metabolic Syndrome, and Inflammation in the Hispanic Community Health Study/Study of Latinos
    Hridya Rao, Michelle L. Meyer, Michelle A. Kominiarek, Martha L. Daviglus, Linda C. Gallo, Christina Cordero, Raveen Syan, Krista M. Perreira, Gregory A. Talavera, Lindsay Fernández‐Rhodes · 2024 · The Journal of Clinical Endocrinology & Metabolism
  40. Unpacking PCOS Inflammation: From Misconceptions to Immune Networks
    Gabriela De Robles, Kiara Dominique Wiggins, Zena D. Del Mundo, Naveena S. Ujagar, Christy M Nguyen, Marcus Michael Seldin, Gabriela Pacheco-Sanchez, Dequina Nicholas · 2025 · Endocrinology
  41. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D
    Manjula Nandakumar, Priya Das, Thozhukat Sathyapalan, Alexandra E. Butler, Stephen Lawrence Atkin · 2024 · International Journal of Molecular Sciences
  42. Factors Associated With Increased Carotid Intima-Media Thickness and Being Nondipper in Nonobese and Normotensive Young Patients Affected by PCOS
    Ebru Akgül Ercan, Sibel Ertek, Gürkan İş, Oya Çağlar, Efser Öztaş, Arrigo F.G. Cicero, Aslıhan Alhan, Şengül Çehreli, Hasan Fehmi Töre, Gürbüz Erdoğan · 2011 · Angiology
  43. Meta-analysis of association between il-6-174 g/c polymorphism and female infertility related disorders
    Jiby Jolly Benjamin, Teena Koshy, K. Mahesh Kumar, K.N. Maruthy, R. Padmavathi · 2020 · Journal of Reproductive Immunology
  44. Correlation of Serum Homocysteine Levels and Hyperinsulinaemia with Body Mass Index in Polycystic Ovarian Syndrome
    Rashmi Bhushan, Parul Sinha · 2022 · Journal of Human Reproductive Sciences
  45. The Inflammatory Gene Pathway Is Not a Major Contributor to Polycystic Ovary Snydrome
    Surabhi Bhatt, Priscilla Mutharasan, Obed A. Garcia, Nadereh Jafari, Richard S. Legro, Andrea Elizabeth Dunaif, Margrit Urbanek · 2014 · The Journal of Clinical Endocrinology & Metabolism
  46. C-reactive protein and lipoprotein-a as markers of coronary heart disease in polycystic ovary syndrome
    Nilgün Güdücü, Herman İşçi, Alin Başgül Yiğiter, İlkkan Dünder · 2012 · Journal of the Turkish-German Gynecological Association
  47. Comparison of Biomedical Variables in PCOS Patients with Normal Iranian Women.
    Maryam Bagheri, Farnaz Sohrabvand, Mahnaz Lankarani, Zahra Zandieh, Fedyeh Haghollahi, Mamak Shariat · 2015 · PubMed Central
  48. Circulating neuregulin-1 levels in polycystic ovary syndrome
    Haldun Arpacı · 2019 · Journal of Obstetrics and Gynaecology
  49. Women with polycystic ovary syndrome are sensitive to the TNF‐α‐lowering effect of glucose‐induced hyperinsulinaemia
    Jardena J. Puder, Sabina Varga, Charly Nusbaumer, Henryk Zulewski, Stefan Bilz, Beat Peter Müller-Stich, Ulrich Bernd Keller · 2006 · European Journal of Clinical Investigation
  50. Evaluation of periodontal status in women with polycystic ovary syndrome versus healthy women: a cross-sectional study
    Sandhya Pavankumar, Pavan Kumar Yellarthi, Sandeep Jn, Ramanarayana Boyapati, Trinath Kishore Damera, Naveen Vital Kumar Gidijala · 2023 · Journal of Yeungnam Medical Science
  51. Molecular and clinical insights into early-onset endometrial cancer
    Zimeng Wu, Zhe Hu, Qinlan Li, Geyan Liu, Ana Oaknin, Juan Francisco Grau-Béjar, Gordon Brent Mills, Ding Ma, Chaoyang Sun, Gang Chen · 2025 · Trends in cancer
  52. A meta-analysis of the effects of vitamin D supplementation on endocrine metabolic and inflammatory markers in patients with polycystic ovarian syndrome
    Baohua Wu, Jun Yao · 2026 · Medicine
  53. Hydroxylation of dihydromyricetin via Beauveria bassiana fermentation enhances its efficacy in improving insulin signaling: Insights into inflammation, oxidative stress, and endoplasmic reticulum stress
    Yong Cheng, Junhao Wu, Yueqing Gao, Beijun Ang, Liduan Yin, Tong Wang, Qiuming Chen, Zhaojun Wang, Maomao Zeng, Jie Chen et al. · 2025 · Food Research International
  54. Genetic variants in central metabolic genes influence some but not all relations of inflammatory markers in a collective with polycystic ovary syndrome
    Birgit Knebel, Stefan Lehr, Onno Eilard Janssen, Susanne Hahn, Ulrike Nitzgen, Sylvia Jacob, Jutta Haas, Dirk Müller‐Wieland, Jörg Kotzka · 2012 · Archives of Physiology and Biochemistry
  55. Influence of hsCRP Parameter on the Occurrence of Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
    Katarzyna Lejman-Larysz, Dominika Pietrzyk, Adrianna Ćwiertnia, Mateusz Kozłowski, Sebastian Kwiatkowski, Iwona Szydłowska, Jolanta Nawrocka-Rutkowska, Jacek Brodowski, Elżbieta Sowińska­‍-Przepiera, Aneta Cymbaluk‐Płoska et al. · 2023 · Biomedicines
  56. The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome
    Selami Demirelli, Hüsnü Değirmenci, Emrah Ermiş, Sinan İnci, Gökay Nar, Mehmet Emin Ayhan, Serdar Fırtına, Hikmet Hamur, Şenay Arıkan Durmaz · 2015 · Biomolecules and Biomedicine
  57. The relationship between epicardial adipose tissue thickness and oxidative stress parameters in patients with isolated polycystic ovary syndrome
    Bülent Demir, Hüseyin Cengiz, İsmail Ünğan, Asuman Gedikbaşı, Gökhan Karakoç, Esra Demir, Nazan Demir · 2015 · Gynecological Endocrinology
  58. Assessment of atrial electromechanical delay in patients with polycystic ovary syndrome in both lean and obese subjects
    Hakan Taşolar, Türkan Mete, Mehmet Ballı, Burak Altun, Mustafa Çetın, Tuncay Yüce, Sevgi Taşolar, Ömür Otlu, Adil Bayramoğlu, Haşan Pekdemir · 2014 · Journal of obstetrics and gynaecology research
  59. Polycystic ovarian disease: an overview
    Gabor T. Kovacs · 2004 · Reviews in Gynaecological Practice
  60. Polycystic Ovarian Syndrome, Biomarkers, and Metformin: Research, Risk, and Reality
    Naveed A. Sattar, Scott McGill Nelson · 2008 · The Journal of Clinical Endocrinology & Metabolism
  61. Effects of Saireito on the ovarian function of patients with polycystic ovary syndrome
    Machi Okamoto, Hideya Sakakibara, Hiroshi Yoshida, Yuka Fukazawa, Kunitomo Takashima, Yoshihito Kondo, Mario Ikeda, Masahiko Ishikawa, Fumiki Hirahara · 2010 · Reproductive Medicine and Biology
  62. Effect of Lifestyle Modification and Metformin Therapy on Emerging Cardiovascular Risk Factors in Overweight Indian Women with Polycystic Ovary Syndrome
    Gadekal Rajagopal, Amaresh Reddy, Chittari Venkata Harinarayan, Vaikkakara Suresh, Aparna Rajeshwar Rao Bitla, Srinivasa P.V.L.N. Rao, Alok Sachan · 2012 · Metabolic Syndrome and Related Disorders
  63. Plasma visfatin levels and mRNA expression of visfatin in peripheral blood mononuclear cells and peripheral blood monocyte-derived macrophages from normal weight females with polycystic ovary syndrome
    Jing Zhang, Lingling Zhou, Liulin Tang, Liangzhi Xu · 2014 · Experimental and Therapeutic Medicine
  64. Clinical Impact of Insulin Resistance in Women with Polycystic Ovary Syndrome
    Maria Mitkova Orbetzova · 2020 · IntechOpen eBooks
  65. Levels of CD 40L and other inflammatory biomarkers in obese and non‐obese women with polycystic ovary syndrome
    Sameh Sarray, Wassim Youssef Almawi · 2016 · American Journal of Reproductive Immunology
  66. Obesity and Polycystic Ovary Syndrome
    Unaiza Qamar, Stephen Lawrence Atkin, Thozhukat Sathyapalan · 2017 · Elsevier eBooks
  67. Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation
    Raoul Orvieto, Naama Fisch-Shvalb, Vered Yulzari‐Roll, Antonio La Marca · 2005 · Gynecological Endocrinology
  68. Effects of insulin-lowering drugs in PCOS: endocrine, metabolic and inflammatory aspects
    K Rautio · 2006
  69. Microbial Fermentation-Derived Dihydroquercetin Derivatives Exhibit Superior Efficacy in Ameliorating Insulin Resistance via JNK/PI3K/AKT Pathway Regulation Compared to Dihydroquercetin
    Yong Cheng, Junhao Wu, Yueqing Gao, Beijun Ang, Qiuming Chen, Zhaojun Wang, Maomao Zeng, Qin Fang, Jie Chen, Zhiyong He et al. · 2025 · Journal of Agricultural and Food Chemistry
  70. Bidirectional Relationship Between Periodontal Disease and Reproductive Disorders: Focus on Polycystic Ovary Syndrome
    Francesca Angiolani, Davide Gerardi, Sara Bernardi, Diana Torge, Serena Bianchi, Maurizio Piattelli, Giuseppe Varvara · 2025 · Oral
  71. Investigating the association between systemic immune-inflammation index and female fertility: a retrospective cohort study
    Quan-Zi Yao, Ruiling Liu, Yiyan Zeng, Xing-Yu Lv, Li-Hong Geng, Yu-Ling Hu, Jia-Liang He, Zhi-Lei Xu, Lijuan Fu, Meihua Bao et al. · 2026 · Journal of Ovarian Research
  72. Comparison of the different PCOS phenotypes based on monocyte to HDL cholesterol ratio
    Cenk Soysal, İsmail Bıyık, Onur İnce, Özlem Erten, Yasemin Taşçı, Nadi Keskın · 2022 · Journal of Obstetrics and Gynaecology
  73. Comparative effects of the antioxidant glutathione with metformin and Diane-35 on hormonal, metabolic, and inflammatory indicators in a DHEA-induced PCOS rat model
    Aslı Coşar, Pınar Özcan, Fatma Başak Tanoğlu, Olgu Enis Tok, Gülçin Özkara, Hikmet Tunç Timur, Çağlar Çetin, Duygu Neccar · 2024 · Gynecological Endocrinology
  74. Effect of metformin on serum ferritin level in women with polycystic ovary syndrome.
    Saeed Behradmanesh, Gholamhossein Ranjbar Omrani, Frida Ghazanfarpour, Azar Baradaran · 2011 · Europe PMC (PubMed Central)
  75. Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study
    Giuseppe Loverro, Giovanni De Pergola, Edoardo Di Naro, Massimo Tartagni, Cristina Lavopa, Anna Maria Caringella · 2010 · Journal of Ovarian Research
  76. Das polyzystische Ovarsyndrom
    Dennis Heutling, H Schulz, Harpal Singh Randeva, Christoph Dodt, Hendrik Lehnert · 2007 · Der Internist
  77. CONTROVERSIES IN ENDOCRINOLOGY : A MODERN MEDICAL QUANDARY: POLYCYSTIC OVARY SYNDROME, INSULIN RESISTANCE AND ORAL CONTRACEPTIVE PILLS
    Evanthia Diamanti‐Kandarakis, Jean‐Patrice Baillargeon, M J Jurno · 2003
  78. Die Insulinresistenz beim polyzystischen Ovar-Syndrom
    Annika K. Schröder, S. Tauchert, Olaf Ortmann, Klaus Diedrich, Jürgen Michael Weiss · 2003 · Wiener klinische Wochenschrift
  79. Do Cardiovascular Risk Factors in Polycystic Ovarian Syndrome Result in More Cardiovascular Events?
    David S. Guzick · 2008 · The Journal of Clinical Endocrinology & Metabolism
  80. CRISPR as a Tool to Uncover Gene Function in Polycystic Ovary Syndrome: A Literature Review of Experimental Models Targeting Ovarian and Metabolic Genes
    Shahd Bucheeri, Yasmine Alcibahy, Yara Bucheeri, Sarah Bucheeri, Abrar Alhermi, Alexandra E. Butler · 2025 · Cells
  81. Oxidative Stress Markers and Heat Shock Proteins in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D
    Manjula Nandakumar, Thozhukat Sathyapalan, Alexandra E. Butler, Stephen Lawrence Atkin · 2023 · Biomedicines
  82. Elucidation of Immune Regulation Mechanism of Renshen Guben Oral Liquid by Network Pharmacology and Molecular Docking
    Yingying Tan, Yingying Liu, Jingyuan Zhang, Jialin Li, Pei-Zhi Ye, Antony Stalin, Xiaotian Fan, Zhihong Huang, Bing Jhang Li, Chao Wu et al. · 2023 · World Journal of Traditional Chinese Medicine
  83. Evaluation of CRP/Albumin Ratio in Polycystic Ovarian Syndrome
    Nandini Upadhyay, Edelbert Anthonio Almeida, Alpana Singh, S. V. Madhu, Dinesh Puri, Mohit Mehndiratta · 2023 · The Journal of Obstetrics and Gynecology of India
  84. Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome
    Ali Ozcan, Aykan Yücel, Volkan Noyan, Nevin Sağsöz, Osman Çağlayan · 2012 · Journal of the Turkish-German Gynecological Association
  85. Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview
    Netal Rathi, Amit R Reche · 2023 · Cureus
  86. [Chronic complications of polycystic ovary syndrome. Review].
    Elsy Velásquez · 2002 · PubMed
  87. Clinical aspects of obesity in the gynecological endocrinologicaly practice
    Andrzej Milewicz, Diana Jędrzejuk · 2006 · Maturitas
  88. Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome?
    Melia Karaköse, Erman Çakal, Oya Toplaoglu, Müyesser Saykı Arslan, Zeynep Giris, Mustafa Şahi̇n, Tuncay Delibaşı · 2013 · Journal of the Turkish-German Gynecological Association
  89. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome
    Katharina Walch, Christoph Grimm, Friedrich Nagele, Johannes C. Huber, Monika Maria Wölfler, Elisabeth Vytiska‐Binstorfer, Gertrud Unfried, Lukas Hefler · 2006 · Acta Obstetricia Et Gynecologica Scandinavica
  90. Research progress on the pathogenesis, clinical impact, and traditional Chinese medicine treatment of polycystic ovary syndrome complicated by insulin resistance
    Zepu Sun, Bao Jin, Han Han, Zhen Qin, Yuqian Shi, Yuehui Zhang · 2025 · Frontiers in Pharmacology
  91. Recent advances in reprogramming lactate metabolism in polycystic ovary syndrome
    Jing Xu, Weihong Chen, Ming-na Huang, Ling‐tao Zheng, Si-Yan Huang, Shu Lin, Qiyang Shi · 2025 · Journal of Ovarian Research
  92. Inflammation and Insulin Resistance in a Group of Sub-Saharan African Women with Polycystic Ovary Syndrome
    Chemaga Nkonpawa C, Vicky Jocélyne Ama Moor, Aurel Tiakouang Tankeu, Audrey Synthia Momo, Guy Sadeu Wafeu, Falmata Amazia, Jan René Nkeck, Tasha Manases, Julius Dohbit Sama, Siméon Pierre Choukem · 2021 · Journal of Inflammation Research
  93. High sensitivity C - reactive protein (hs-CRP) and clinical characteristics, endocrine, metabolic profile in Indian women with PCOS: a correlation
    Sunita Jaiprakash Ramanand, Jaiprakash B. Ramanand, Girish Raparti, Ravi R. Ghanghas, Nimish R. Halasawadekar, Praveenkumar T. Patil, Mayur Pawar, Mayur Shinde · 2014 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  94. High-Sensitivity C-Reactive Protein in Patients with Polycystic Ovary Syndrome
    Cristian Ioan Iuhas, Nicolae Costin, Dan Mihu · 2012 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
  95. Polycystic Ovary Syndrome Triggers Atrial Conduction Disorders: A Systematic Review and Meta-Analysis
    Dimitrios V. Moysidis, Αndreas S. Papazoglou, Christos Tsagkaris, Vasileios Oikonomou, Anna Loudovikou, Αναστάσιος Κάρτας, Nikolaos Stalikas, Efstratios Karagiannidis, Mihnea‐Alexandru Găman, Marios Papadakis et al. · 2022 · European Journal of Investigation in Health Psychology and Education
  96. Cardiovascular Risk Predictors High Sensitivity C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Women with Lean Phenotype of Polycystic Ovarian Syndrome: A Prospective Case-Control Study
    Ashok Kumar Shah, Birendra Kumar Yadav, Amrendra Kumar Shah, Arpita Suri, Saurabh K. Deo · 2022 · Journal of Laboratory Physicians
  97. Abnormalities of Hormones and Inflammatory Cytokines in Women Affected With Polycystic Ovary Syndrome
    Dakhel Ghani Omran AL-Watify · 2014 · Journals & Books Hosting (International Knowledge Sharing Platform)
  98. Profile of Daughters and Sisters of Women With Polycystic Ovary Syndrome: The Role of Proband’s Glucose Tolerance
    Soren Harnois‐Leblanc, María Isabel Hernández, Ethel Codner D, FERNANDO G. CASSORLA, Sharon E. Oberfield, Natasha I. Leibel, Revi P. Mathew, Svetlana Ten, Denis A. Magoffin, Christianne Joy Lane et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
  99. Inflammation and Conception in a Prospective Time-to-Pregnancy Cohort
    Anne Marie Z. Jukic, Clarice R. Weinberg, Sunni L. Mumford, Anne Z. Steiner · 2022 · Epidemiology
  100. Procalcitonin as a Mediator of Chronic Inflammation in Obese Women with PCOS
    Nadia Mudher Al-Hilli, Haydar Hashim Al-Shalah · 2010 · Medical Journal of Babylon